Qol Holdings Co's ROE % for the quarter that ended in Mar. 2026 was 19.52%. Qol Holdings Co's PB Ratio for the quarter that ended in Mar. 2026 was 1.22.
Qol Holdings Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 16.00%.
Qol Holdings Co ROE % Adjusted to Book Value Related Terms
Qol Holdings Co ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Qol Holdings Co's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co ROE % Adjusted to Book Value Chart
Qol Holdings Co ROE % Adjusted to Book Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Qol Holdings Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qol Holdings Co ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Qol Holdings Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 16.00% mean?
Qol Holdings Co (TSE:3034) has a ROE % Adjusted to Book Value of 16.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Qol Holdings Co and its competitors.
Is Qol Holdings Co's ROE % Adjusted to Book Value too high?
Qol Holdings Co's current ROE % Adjusted to Book Value is 16.00%. Overall, Qol Holdings Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qol Holdings Co's ROE % Adjusted to Book Value compare to competitors?
Qol Holdings Co's ROE % Adjusted to Book Value of 16.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Qol Holdings Co and its competitors. Qol Holdings Co's current ROE % Adjusted to Book Value is 16.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qol Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Qol Holdings Co (TSE:3034) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,278.91, compared to a current price of 円2,008.00 — trading 11.9% below its estimated fair value. The current ROE % Adjusted to Book Value is 16.00%. Qol Holdings Co's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Qol Holdings Co (TSE:3034), the current ROE % Adjusted to Book Value is 16.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qol Holdings Co (TSE:3034) Overvalued in 2026?
Based on GuruFocus' analysis, Qol Holdings Co stock appears to be undervalued.
The current stock price of 円2,008.00 is trading 11.9% below its estimated GF Value™ of 円2,278.91.
GuruFocus considers Qol Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:3034:
ROE % Adjusted to Book Value: 16.00%
GF Value™: 円2,278.91 vs. price of 円2,008.00 (11.9% below fair value)
No single metric tells the full story. See the TSE:3034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
87GF Score
Get the complete analysis for TSE:3034
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3034 has been successfully added to your 
